FDA crackdown targets unpublished research results

Posted 3 hours ago by

Off The Press

The U.S. Food and Drug Administration issued more than 2,200 notices urging companies and researchers to comply with federal publication rules. A recent FDA crackdown highlights transparency issues in clinical research, as thousands of companies and researchers have failed to disclose required trial results. Some of the agency’s reminders went to taxpayer-funded projects.